The page below gives primary care clinicians guidance on how to recognise and refer a patient with a possible prosthetic joint infection following hip replacement surgery.
Prosthetic Joint Infection (PJI)
Full Guidelines
INFORM Guideline for hip PJI_v1.2.pdf (bristol.ac.uk)
A prosthetic joint infection should be suspected in:
Early recognition is crucial to prevent progression to a severe, life-altering condition that is difficult to treat and potentially leads to severe disability or death.
If in doubt, contact your local hospital and treating orthopaedic department.
Do not start antibiotic treatment in the community
Without identification of the infecting organism, pre-emptive treatment with antibiotics in primary care may delay identification of the infecting organism or make decision making and surgical management more difficult. The orthopaedic team must collect samples before antibiotics are started to optimise identification of the infecting organism.
All patients with suspected peri-prosthetic joint infection should be dealt with on an urgent basis as outlined above.
If a patient presents with signs of sepsis then call 999 / arrange emergency transfer to ED.
Where PJI is suspected DO NOT DELAY in referral to treating orthopaedic team.
Referral can be made back to the treating Orthopaedic team in hours, or to the on call team (available via switchboard) at the local hospital/trauma unit out of hours.
Evidence
“Approach to patients with a potential prosthetic joint infection”. BMJ 2022; 376 doi:
https://doi.org/10.1136/bmj-2021-069502
Regional/Tertiary Prosthetic Joint Infection Services
Prosthetic Joint Infection Service | North Bristol NHS Trust (nbt.nhs.uk)
Guidelines
INFORM Guideline for hip PJI_v1.2.pdf (bristol.ac.uk)
Mental health
Consider referral to NHS Talking Therapies for mental health support.
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.